156 related articles for article (PubMed ID: 7511441)
1. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes.
Yoshino T; Kondo E; Cao L; Takahashi K; Hayashi K; Nomura S; Akagi T
Blood; 1994 Apr; 83(7):1856-61. PubMed ID: 7511441
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of Fas and Fas ligand on peripheral blood lymphocytes in normal subjects.
Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Koji T; Urayama S; Nakashima T; Kawabe Y; Nagataki S
J Lab Clin Med; 1998 Nov; 132(5):404-13. PubMed ID: 9823934
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.
Iwai K; Miyawaki T; Takizawa T; Konno A; Ohta K; Yachie A; Seki H; Taniguchi N
Blood; 1994 Aug; 84(4):1201-8. PubMed ID: 7519477
[TBL] [Abstract][Full Text] [Related]
5. Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen.
Ito M; Watanabe M; Ihara T; Kamiya H; Sakurai M
Cell Immunol; 1995 Feb; 160(2):173-7. PubMed ID: 7536633
[TBL] [Abstract][Full Text] [Related]
6. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
7. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
Tamura A; Yui K
J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
[TBL] [Abstract][Full Text] [Related]
9. Actinobacillus actinomycetemcomitans induces apoptosis of T lymphocytes by the Fas and Fas ligand pathway.
Nalbant A; Zadeh HH
Oral Microbiol Immunol; 2002 Oct; 17(5):277-84. PubMed ID: 12354208
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients.
Massaia M; Borrione P; Attisano C; Barral P; Beggiato E; Montacchini L; Bianchi A; Boccadoro M; Pileri A
Blood; 1995 Jun; 85(12):3679-87. PubMed ID: 7540069
[TBL] [Abstract][Full Text] [Related]
11. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
[TBL] [Abstract][Full Text] [Related]
12. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.
Strasser A; Harris AW; Huang DC; Krammer PH; Cory S
EMBO J; 1995 Dec; 14(24):6136-47. PubMed ID: 8557033
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.
Ohsako S; Hara M; Harigai M; Fukasawa C; Kashiwazaki S
Clin Immunol Immunopathol; 1994 Oct; 73(1):109-14. PubMed ID: 7523011
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death (apoptosis) in cord blood lymphocytes.
Aggarwal S; Gupta A; Nagata S; Gupta S
J Clin Immunol; 1997 Jan; 17(1):63-73. PubMed ID: 9049787
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a monoclonal antibody that reacts with an activation antigen on human B cells: reactions on mitogen-stimulated blood lymphocytes and cells of normal lymph nodes.
Frisman D; Slovin S; Royston I; Baird S
Blood; 1983 Dec; 62(6):1224-9. PubMed ID: 6416334
[TBL] [Abstract][Full Text] [Related]
18. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts.
Tung TC; Oshima K; Cui G; Laks H; Sen L
Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H964-73. PubMed ID: 12915385
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
Bosque A; Pardo J; Martínez-Lorenzo MJ; Iturralde M; Marzo I; Piñeiro A; Alava MA; Naval J; Anel A
J Leukoc Biol; 2005 Apr; 77(4):568-78. PubMed ID: 15653751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
